Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Àü¸³¼±ºñ´ëÁõ ȯÀÚ¿¡ ´ëÇÑ °£Áú¼º ·¹ÀÌÀúÀÀ°í¼úÀÇ Ãʱâ°æÇè Early Clinical Experience of Interstitial Coagulation(ILC) for the Treatment of Benign Prostatic Hyperplasia

´ëÇѺñ´¢±â°úÇÐȸÁö 1999³â 40±Ç 2È£ p.201 ~ 206
±è°æ½Ä, ¿À¹®¸ñ,
¼Ò¼Ó »ó¼¼Á¤º¸
±è°æ½Ä (  ) 
¼º¾Öº´¿ø ºñ´¢±â°ú

¿À¹®¸ñ (  ) 
¼º¾Öº´¿ø ºñ´¢±â°ú

Abstract

°á·Ð
1996³â 4¿ùºÎÅÍ 1997³â 1¿ù±îÁö Àü¸³¼±ºñ´ëÁõÀ¸·Î º»¿ø¿¡ ³»¿øÇÑ È¯ÀÚÁß 16¸íÀ» ´ë»óÀ¸·Î
Indigo Medical ȸ»çÀÇ Indigo 830eTM Laser Optic Treatment System¸¦ ÀÌ
¿ëÇÑ °£Áú¼º ·¹ÀÌÀúÀÀ°í¼úÀ» ½ÃÇàÇÏ¿© ¼ö¼ú Àü°ú ¼ö¼ú ÈÄ 1°³¿ù ¹× 2°³¿ù °ÀÇ ±¹Á¦Àü¸³¼±
Áõ»óÁ¡¼ö, »îÀÇ Áú, ÃÖ´ë¿ä¼Ó, Æò±Õ¿ä¼Ó, ÀÜ´¢·® µîÀ» ºñ±³ÇÏ¿© Ä¡·áÈ¿°ú¸¦ ºÐ¼®ÇÏ°í ÇÕº´Áõ
À» °ËÅäÇÏ¸ç º» °á°ú, °£Áú¼º ·¹ÀÌÀúÀÀ°í¼úÀº Ä¡·áÈ¿°ú°¡ ¸Å¿ì ¿ì¼öÇϸ鼭µµ ½Ã¼úÀÌ ºñ±³Àû
°£´ÜÇÏ°í ºñħ½ÀÀûÀÎ ¹æ¹ýÀ¸·Î ÃâÇ÷ ¹× ÀüÇØÁúÀÌ»óÀÌ °ÅÀÇ ¾ø¾î Àü½Å»óÅ°¡ ºÒ·®ÇÑ °í·ÉÀÇ
ȯÀÚ¿Í Àü¸³¼± Å©±â°¡ Ä¿¼­ °æ¿äµµÀü¸³¼±ÀýÁ¦¼úÀ» ½ÃÇàÇϱ⠾î·Á¿î ȯÀÚ¿¡¼­µµ ¾ÈÀüÇÏ°Ô ½Ã
ÇàÇÒ ¼ö ÀÖ´Â È¿°úÀûÀÎ Ä¡·á¹ýÀ̶ó »ý°¢µÈ´Ù.

Purpose : Variable modalities, with more comfortable and less incidence of
post-operative complications over TURP, have been used for the treatment of benign
prostatic hyperplasia(BPH) with bladder outlet obstruction. Recently, we performed
Interstitial Laser Coagulation(ILC) with the 830nm diode laser, which is considered as a
method of minimally invasive treatments for BPH, to assess the efficacy and safety of
the device, and to evaluate its capability of replacing TURP for managing BPH.
Materials and Methods : We analysed 16 patients, who had suffered from symptomatic
BPH, treated with ILC using diode laser retrospectively from April 1996 to January 1997.
Mean age of the patients was 71.7(52-84) years old and mean size of prostates before
the treatments was 52.2(26.8-100.7)gm. Treatment outcome was estimated by comparing
IPSS, QOL, Qmax, Qave and residual urine before the operations with them of first and
second month after the operations. Post-operative transrectal ultrasonography was able
to several cooperative cases and they were compared with them of pre-operative
volumes, too, although it was unavailable to evaluate statistically.
Results : The operation were performed under epidural or spinal anesthesia with
average time of 62 minutes and with 10 days of post-operative catheterization. IPSS
reduced from 22.25(¡¾4.82), mean value before the operation, to 11.00(¡¾5.58) and 5.00(¡¾
3.10) at first and second month after ILC. QOL was gradually decreased from 4.44(¡¾
0.51) to 2.31(¡¾1.20) and 1.19(¡¾0.91), too. In terms of Qmax, mean was 12.29(¡¾5.55)§¢
/sec before the operation and it was increased to 15.94(¡¾7.38)§¢/sec and 20.75(¡¾8.48)§¢
/sec. Average flow rate was also increased from 6.98(¡¾2.05)§¢/sec to 10.38(¡¾3.72)§¢/sec
and 14.93(¡¾4.37)§¢/sec. Significant reduction was observed in residual urine volume
from 98.13(¡¾91.72)§¢ to 33.19(¡¾36.58)§¢ and 9.56(¡¾11.24)§¢ respectively. Minimal
hematuria and mild bladder irritations were common symptoms after the procedure, and
possible significant complications as like anemia, electrolyte imbalance(post-TUR
syndrome), epididymoorchitis, erectile dysfunction, urethral stricture, retrograde
ejaculation had not found in our experience, but 1 patient was retreated with TURP
because of continued bladder outlet obstruction.
Conclusions : Our initial results with ILC showed that it is a relatively simple and
minimally invasive method with minimal occurrence of bleeding and no electrolyte
imbalance. We concluded that ILC is a safe and efficacious treatment modality, and it
can be used even for elder patients with co-morbidity illness as well as patients with
too large prostate to perform TURP.

Å°¿öµå

Benign prostatic hyperplasia; Diode laser; Interstitial laser coagulation of prostate;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS